Endocytosing the death sentence.
Griffiths
Gillian M
GM
Sir William Dunn School of Medicine, Oxford OX1 3RE, United Kingdom. gillian.griffiths@path.ox.ac.uk
D000818:Animals; D017209:Apoptosis / Q000276:immunology*; D004705:Endocytosis / Q000276:immunology*; D053804:Granzymes; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism*; D008247:Lysosomes / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D017527:Receptor, IGF Type 2 / Q000276:immunology* / Q000378:metabolism; D012697:Serine Endopeptidases / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism*
D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D017527:Receptor, IGF Type 2; D054353:Perforin; C509213:GZMB protein, human; D053804:Granzymes; D012697:Serine Endopeptidases